| Financial Year |
March 31 2023 |
| Monetary Funds |
40,298,552,984.00 |
| Held-for-trading Financial Assets |
12,797,268,530.00 |
| Notes Receivable |
234,380,811.00 |
| Accounts Receivable |
5,410,439,279.00 |
| Advances to Suppliers |
4,039,269,790.00 |
| Other Receivables |
4,996,720,779.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,129,271,268.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
326,612,466.00 |
| Other Current Assets |
4,701,304,666.00 |
| Total Current Assets |
116,376,527,877.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,013,315,483.00 |
| Investment Properties |
841,677,290.00 |
| Fixed Assetes |
22,798,905,253.00 |
| Under-construction Projects |
5,530,164,407.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,337,076,871.00 |
| R&D expenses |
593,050,969.00 |
| Goodwill |
1,295,673,661.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
706,514,475.00 |
| Other Non-Current Assets |
7,490,697,293.00 |
| Sub-Total of Non-Current Assets |
73,768,109,125.00 |
| Total Assets |
190,144,637,002.00 |
| Short-Term Loans |
47,564,809,603.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,509,378,308.00 |
| Accounts Payable |
8,354,008,549.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,381,148,656.00 |
| Taxes Payable |
1,309,180,676.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,731,886,971.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,223,291,741.00 |
| Other Current Liabilities |
8,805,125,960.00 |
| Sub-Total of Current Liabilities |
83,535,095,462.00 |
| Long-term Loans |
15,120,579,188.00 |
| Bonds Payable |
3,500,000,000.00 |
| Long-Term Accounts Payable |
1,181,307,796.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
348,651,203.00 |
| Deferred Income Tax Liabilities |
354,839,568.00 |
| Other Non-Current Liabilities |
33,308,420.00 |
| Sub-Total of Non-Current Liabilities |
21,029,050,485.00 |
| Total Liabilities |
104,564,145,947.00 |
| Paid-In Capital(Or Share Stock) |
3,462,729,405.00 |
| Capital Surplus |
11,158,309,484.00 |
| Surplus Reserve |
15,985,053,092.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
33,126,533,640.00 |
| Minority Stockholder's Interest |
8,633,869,247.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
76,946,621,808.00 |
| Owner's Equity（Stockholder's Equity） |
85,580,491,055.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
190,144,637,002.00 |
